Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 57 filings·Updated 22 Aug 2026
Showing 10 of 57 filings.
22 Aug 20261 filing
AGM/EGMEGM

Integrated Proteins Ltd EGM approves 1:10 share split, MOA changes, and director appointments

EGM overview

  • EGM held on 20 Aug 2026 via VC/OAVM to approve share subdivision.
  • Resolutions include MOA alterations and key director appointments.
  • Total four resolutions passed with 100% voting in favour.
  • Promoter group had no interest in the agenda.

Resolution 1 – Share subdivision

  • Type: Ordinary; sub-division of equity shares from Rs 10 to Rs 1.
  • Promoter interest: No promoter group interested.
  • Outcome: Approved; 100% assent.
  • Impact: Share count increases; ownership and control unchanged.

Resolution 2 – MOA alteration

  • Type: Ordinary; MOA capital clause altered for subdivision.
  • Promoter interest: No.
  • Outcome: Approved; 100% assent.

Resolution 3 – NED appointment

  • Type: Ordinary; Appoints Nitish Pratapray Mehta as Non-Executive Independent Director.
  • Promoter interest: No.
  • Outcome: Approved; 100% assent.

Resolution 4 – MD/Chairman appointment

  • Type: Special; Appoints Hiren Dhirajlal Shah as Chairman and Managing Director.
  • Promoter interest: No.
  • Outcome: Approved; 100% assent.

Voting & attendance

  • Total voters: 12; total shares voted: 7,022,335.
  • Remote e-voting and EGM results: all resolutions passed.
  • Promoter group participation: none in voting.
  • Share-subdivision impact: no change in control.

Governance impact

  • MD/Chairman appointment and NED appointment enhance governance structure.
Filed 23:24View Source
21 Aug 20261 filing
Corp. ActionRecord Date

Integrated Proteins fixes record date for 1:10 equity share subdivision effective for entitlement

Record date and split details

  • Sub-division of equity shares from ₹10 to ₹1, ratio 1:10, fully paid.
  • Record date fixed as Friday, 4 September 2026.
  • Approved by members at the Extraordinary General Meeting on 20 August 2026.
  • Security: equity shares; post-split face value ₹1.
Filed 16:55View Source
20 Aug 20261 filing
AGM/EGMEGM

Integrated Proteins EGM proposes share subdivision, capital clause change, director regularisation, and CMD re-appointment; results pending

Resolutions proposed

  • Resolution 1 (Ordinary): Sub-division of ₹10 shares into 10×₹1 each.
  • Resolution 2 (Ordinary): Alteration of Capital Clause due to subdivision.
  • Resolution 3 (Ordinary): Regularisation of Nitesh Pratapray Mehta as Non-Executive Director.
  • Resolution 4 (Special): Re-appointment of Hiren Shah as CMD for five years (24 Jul 2026–23 Jul 2031).
Filed 16:27View Source
15 Aug 20261 filing
Company UpdateNewspaper Publication

Submission of copies of newspaper advertisement for the financial result for Quarter ending June, 2026

Filed 14:41View Source
14 Aug 20261 filing
Board MeetingOutcome of Board Meeting

Integrated Proteins Ltd board approves unaudited standalone Q1 FY2026 results with limited review

Financial results

  • Board approved unaudited standalone results for quarter ended 30-06-2026; Limited Review Report attached
  • Revenue from operations ₹1,054.73 lakh; Other income ₹1.65 lakh; Total ₹1,056.38 lakh
  • Total expenses ₹1,007.93 lakh; Profit before tax ₹48.45 lakh; Tax ₹12.19 lakh; Net profit ₹36.26 lakh
  • Earnings per share: Basic ₹0.19; Diluted ₹0.19; Paid-up equity capital ₹1,871.36 lakh
  • Audit Committee reviewed results; Board approved and release dated 14 August 2026
  • Notes: Standalone results; IND AS 34; segment information disclosed per IND AS 108

Auditors' remarks

  • Independent Auditor's Review Report states no material misstatement; no audit opinion issued

Governance / approvals

  • Meeting held at Jamnagar; Managing Director Hiren Shah signed on behalf of the company
  • Date: 14 August 2026; results released under Regulation 33 SEBI LODR
  • No material director or auditor changes disclosed
Filed 16:09View Source
10 Aug 20261 filing
Board Meeting

Integrated Proteins to consider unaudited quarterly results for quarter ended June 30, 2026

Meeting Details

  • Date: August 14, 2026.
  • Location: Registered Office, Office No. 218, Manek Centre, Pandit Nehru Marg, Jamnagar, Gujarat.

Key Agenda Items

  • Consider and approve unaudited financial results for quarter ended June 30, 2026, with Limited Review Report.
  • Any other item with permission of Chair and majority of directors.

Other Notes

  • No additional material items beyond the stated agenda.
Filed 22:27View Source
30 Jul 20261 filing
Company UpdateNewspaper Publication

Newspaper Advertisement- Notice of Extra Ordinary General Meeting

Filed 11:26View Source
28 Jul 20261 filing
AGM/EGMEGM

Integrated Proteins Ltd EGM to sub-divide shares, alter capital, and regularise directors including CMD appointment

Resolution 1: Share sub-division

  • Ordinary; sub-divide equity shares 10:1, record date to be fixed, listing approvals required.

Resolution 2: Capital clause alteration

  • Ordinary; alter authorized capital to Rs25 crore, Rs1 per share, increasing share count to 25,00,00,000 shares.

Resolution 3: Regularize Nitish Mehta as NED

  • Ordinary; regularize Nitish Mehta as Non-Executive Director; appointed as additional director on 9 July 2026.

Resolution 4: CMD appointment

  • Special; reappoint Hiren Shah as CMD for five years (Jul 2026–Jul 2031) with approved remuneration.
Filed 18:47View Source
27 Jul 20261 filing
OthersOutcome without intimation

Integrated Proteins: Company Secretary and Compliance Officer resigns effective July 27, 2026

Appointments/Resignations

  • Shivangi Paliwal resigned as Company Secretary and Compliance Officer; effective 27 July 2026; due to personal reasons.
Filed 17:50View Source
24 Jul 20261 filing
Company UpdateChange in Directorate

Hiren Shah redesignated Chairman and Managing Director for five-year term, subject to shareholder approval

Director designation change

  • Re-designation of Hiren D. Shah from Additional Executive Director to Chairman and Managing Director.
  • Effective 24 July 2026 for a five-year term until 23 July 2031.
  • Subject to shareholders' approval at the general meeting.
  • Profile: BCA and LL.B from Saurashtra University; extensive finance and corporate management experience.
  • Not debarred from holding office by SEBI or any authority.
  • Relationship with other directors: None disclosed.
Filed 21:50View Source
Showing 10 of 57 filings